Differential behavioural effects of chronic infusion of CRH1 and CRH2 receptor antisense oligonucleotides into the rat brain

Journal of Psychiatric Research

Volumn 33, Issue 2, 1999, Pages 153-163

  Liebsch, G ^a   Landgraf, R ^a   Engelmann, M ^a   Lorscher P ^a   Holsboer, F ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CORTICOTROPIN RELEASING FACTOR; HORMONE RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; EMOTION; FEMALE; FORCED SWIMMING TEST; LATERAL BRAIN VENTRICLE; LEARNING; LOCOMOTION; MALE; MAZE TEST; NEWBORN; NONHUMAN; OPEN FIELD BEHAVIOR; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SOCIAL BEHAVIOR; TRANQUILIZING ACTIVITY;

EID: 0033011766     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)80047-2     Document Type: Article

References (48)

1. Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol Psychiatry 1996;1:265-277.
2. Behan DP, Heinrichs SC, Troncoso JC, Liu X-J, Kawas CH, Ling N, De Souza EB. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995;378:284-287.
3. Brandeis R, Brandys Y, Yehuda S. The use of the Morris water maze in the study of memory and learning. Int J Neurosci 1989;48:29-69.
4. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific sub-cortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995;15:6340-6350.
5. Dantzer R, Bluthé RM, Kelley KW. Androgen-dependent vasopressinergic neurotransmission attenuates interleukin 1-induced sickness behavior. Brain Res 1991;557:115-120.
6. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Rev 1990;15:71-100.
7. Engelmann M, Wotjak CT, Landgraf R. The social discrimination procedure: an alternative method to investigate juvenile recognition abilities in rats. Physiol Behav 1995;58:315-321.
8. 1 antagonists. Annu Rep Med Chem 1997;32:41-50.
9. Harro J. Measurement of exploratory behavior in rodents. Methods Neurosci 1993;14:359-377.
10. Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res 1992;581:190-197.
11. Heinrichs SC, Menzaghi F, Pich EM, Baldwin HA, Rassnick S, Britton KT, Koob GF. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to Stressors of varying type and intensity. Neuropsychopharmacology 1994;11:179-186.
12. 2, receptors mediate anxiogenic-like behavior. Regul Peptides 1997a;71:15-21.
13. Heinrichs SC, Vale EA, Lapansky J, Behan DP, McClure LV, Ling N, De Souza EB, Schulteis G. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides 1997b;18:711-716.
14. Heit S, Owens MJ, Plotsky P, Nemeroff CB. Corticotropin-releasing factor, stress and depression. Neuroscientist 1997;3:186-194.
15. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev 1996;17:187-205.
16. Iredale PA, Terwilliger R, Widnell KL, Nestler EJ, Duman RS. Differential regulation of corticotropin-releasing factor, receptor expression by stress and agonist treatments in brain and cultured cells. Mol Pharmacol 1996;50:1103-1110.
17. Koob GF, Heinrichs SC, Menzaghi F, Pich EM, Britton KT. Corticotropin-releasing factor, stress and behavior. Semin Neurosci 1994;6:221-229.
18. Kovacs GL, De Wied D. Peptidergic modulation of learning and memory processes. Pharmacol Rev 1994;46:269-291.
19. Kumar KB, Karanth KS. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats. J Neural Trans 1996;103:1117-1126.
20. Lahmame A, Grigoriadis DE, De Souza EB, Armario A. Brain corticotropin-releasing factor immunoreactivity and receptors in five inbred rat strains: relationship to forced swimming behavior. Brain Res 1997;750:285-292.
21. Landgraf R. Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay. Endokrinologie 1981;78:191-204.
22. Landgraf R, Gerstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F, Engelmann M. V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities and anxiety-related behavior in rats. J Neurosci 1995;15:4250-4258.
23. Landgraf R. Antisense targeting in behavioural neuroendocrinology. J Endocrinol 1996;151:333-340.
24. Landgraf R, Naruo T, Miklos V, Neumann I. Neuroendocrine and behavioral effects of antisense oligonucleotides. Eur J Endocrinol 1997;137:326-335.
25. Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M, Holsboer F, Montkowski A. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Peptides 1995;59:229-239.
26. Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M, Holsboer F, Montkowski A. Antisense targeting of CRH receptors in the rat brain: effects on anxiety-related behavior. Neuroforum 1996;February (Special Edition): 192.
27. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. Cloning and characterization of a functionally distinct cotricotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995a;92:836-840.
28. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995b;136:3351-3355.
29. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U, Moreau JL. A non-peptidic corticotropin-releasing factor receptor, antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 1996;309:195-200.
30. Martí J, Armario A. Effects of diazepam and desipramine in the forced swimming test: influence of previous experience with situation. Eur J Pharmacol 1993;236:295-299.
31. Miczek KA. A new test for aggression in rats without aversive stimulation: differential effects of D-amphetamine and cocaine. Psychopharmacology 1979;60:253-259.
32. Montkowski A, Skutella T, Liebsch G, Behl C, Langraf R, Holsboer F. Antisense 'knockdown' of CRH 1, but not of CRH 2, receptors is anxiolytic in rats. Biol Psychiatry 1996;39:566-567.
33. Moreau JL, Kilpatrick G, Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 1997;8:1697-1701.
34. Morris RGM. Spatial localization does not require the presence of local cues. Learning Motivation 1981;12:239-260.
35. Nicot A, Pfaff DW. Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: some prospects and problems. J Neurosci Methods 1997;71:45-53.
36. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991;43:425-473.
37. Paxinos G, Watson C. The Rat brain in stereotaxic coordinates. 2nd ed. Orlando: Academic Press, 1986.
38. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-167.
39. Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993;133:3058-3061.
40. Pich EM, Heinrichs SC, Rivier C, Miczek KA, Fisher DA, Koob GF. Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats. Psychoneuroendocrinology 1993;18:495-507.
41. Porsolt RD, LePichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatment. Nature 1977;266:730-732.
42. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sei USA 1994;91:8777-8781.
43. Primus RJ, Yevich E, Baltazar C, Gallager DW. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychophrmacology 1997;17:308-316.
44. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Ill TFD, Winston EN, Chen YL, Heym J. CP-154, 526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 1996;93:10477-10483.
45. Turnbull AV, Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 1997;215:1-10.
46. Vale W, Vaughan J, Perrin M. Corticotropin-releasing factor (CRF) family of ligands and their receptors. Endocrinologist 1997;7:3S-9S.
47. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287-292.
48. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 1993;259:528-531.